Consistent with the enhanced tumor suppression following ST bsAb treatment, the level of proinflammatory cytokines such as IL‐10 and CCL4 that inhibit anti‐tumor immunity was significantly decreased (Figure 6c). This evidence concerns the gene IL10 and neoplasm.